How We Built It
The No-Go List™ was developed in collaboration with Sorette's Scientific Advisory Board and the team at Habitable, drawing from a comprehensive set of global regulatory and scientific reference sources. Rather than relying on a single authority, we cross-reference multiple hazard and restriction frameworks, with particular consideration for ingredients that raise concerns around reproductive health, hormonal disruption, developmental toxicity, and infant and pediatric endpoints.
Our approach is precautionary by design. Where credible evidence of concern exists, even where regulatory consensus has not yet fully caught up, we err on the side of caution. This is especially true for ingredients appearing in products used during fertility, pregnancy, postpartum, and early parenting stages.
We also apply elevated scrutiny to fragrance and essential oil ingredients. Full disclosure of all components labeled as fragrance, parfum, or natural flavors (both above and below 100 ppm) is required. This allows us to screen for No-Go List™ ingredients even in trace amounts.
How It Applies to Your Product
The No-Go List™ applies to personal care and diapers & wipes submissions. Infant formula is reviewed under a separate framework — Sorette's Infant Formula Transparency Review. If you are submitting an infant formula product, you can learn more about that process here.
When you submit a personal care or diapers & wipes product for the Sorette Seal of Approval, your full formulation is screened against the No-Go List™. This means every ingredient — including fragrance components, processing aids, and incidental additives — is reviewed.
Products are evaluated in one of three ways. A product containing a prohibited ingredient is ineligible for the Seal. A product containing a restricted ingredient is assessed against acceptable concentration thresholds. A product containing neither is eligible to move forward in the review process.
Sorette may request additional documentation during review if clarification is needed on any ingredient. Incomplete or inconsistent disclosures will delay or disqualify a submission.
